Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal Mesh
12:27pm, Tuesday, 17'th Aug 2021
Final results from postmarket surveillance studies of Boston Scientific Corporation's (NYSE: BSX) transvaginal mesh for pelvic organ prolapse (POP) have reinforced the FDA's unfavorable view of the
Boston Scientific (BSX) Just Overtook the 20-Day Moving Average
11:26am, Monday, 16'th Aug 2021
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval
06:34am, Wednesday, 11'th Aug 2021
The FDA has given 510(k) clearance for Boston Scientific Corp's (NYSE: BSX) Exalt Model B single-use bronchoscope for use in bedside procedures within the intensive care unit and operating room. The
Boston Scientific Receives FDA Clearance for EXALT™ Model B Single-Use Bronchoscope
04:00pm, Tuesday, 10'th Aug 2021
MARLBOROUGH, Mass., Aug. 10, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT™ Model B Single-Use
NVST or BSX: Which Is the Better Value Stock Right Now?
01:50pm, Friday, 06'th Aug 2021
NVST vs. BSX: Which Stock Is the Better Value Option?
Boston Scientific Starts Trial For EkoSonic Endovascular System In Patients With Pulmonary Embolism
12:40pm, Wednesday, 04'th Aug 2021
Boston Scientific Corporation (NYSE: BSX) began enrollment for a clinical trial of its EkoSonic endovascular system (EKOS). Boston Scientific's HI-PEITHO trial, a collaborative research study, will
CMS Grants Additional Reimbursement For EXALT™ Model D Single-Use Duodenoscope
04:55pm, Monday, 02'nd Aug 2021
MARLBOROUGH, Mass., Aug. 2, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) fo
Will Boston Scientific Stock See Higher Levels?
07:00am, Monday, 02'nd Aug 2021
Following a solid performance in Q2, Boston Scientific raised its full year outlook for sales to increase 19-20% and adjusted earnings to be in the range of $1.58-$1.62 per share.
Final Trades: Salesforce, Amazon, Boston Scientific & more
02:29pm, Friday, 30'th Jul 2021
The "Halftime Report" traders give their top picks to watch for the second half.
Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q2 2021 Results - Earnings Call Transcript
03:48pm, Tuesday, 27'th Jul 2021
Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q2 2021 Results - Earnings Call Transcript
Why Boston Scientific Shares Are Trading Higher Today
03:26pm, Tuesday, 27'th Jul 2021
Boston Scientific (NYSE:BSX) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also issued FY21 EPS guidance with a midpoint above analyst
Boston Scientific (BSX) Q2 Earnings Beat, 2021 Guidance Up
12:15pm, Tuesday, 27'th Jul 2021
Organic revenues at each of Boston Scientific's (BSX) core business segments and geographies increase in Q2.
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
09:14am, Tuesday, 27'th Jul 2021
Boston Scientific (BSX) delivered earnings and revenue surprises of 8.11% and 4.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific Announces Results For Second Quarter 2021
06:30am, Tuesday, 27'th Jul 2021
MARLBOROUGH, Mass., July 27, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.077 billion during the second quarter of 2021, growing 53.6 percent on a reported
Should You Buy Boston Scientific (BSX) Ahead of Earnings?
10:00am, Monday, 26'th Jul 2021
Boston Scientific (BSX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
